Amlodipine in pregnancy
Pro Research Analysisby 
Searched over 200M research papers
Amlodipine Use During Pregnancy: Safety, Efficacy, and Outcomes
Safety of Amlodipine in Early Pregnancy
Amlodipine, a calcium channel blocker commonly used to treat hypertension, has been evaluated for its safety during early pregnancy. A study involving 231 women with chronic hypertension assessed the frequency of morphological abnormalities in their offspring. The study found no significant difference in the odds of birth defects between neonates exposed to amlodipine in the first trimester and those exposed to other antihypertensives or no antihypertensives at all . Another analysis of a large database from Japan also concluded that first-trimester exposure to amlodipine does not significantly increase the risk of major congenital malformations .
Efficacy of Amlodipine in Managing Hypertension During Pregnancy
A pilot clinical trial compared the efficacy and safety of amlodipine, furosemide, and aspirin in pregnant women with mild to moderate chronic hypertension. The study found no significant differences in maternal complications, pre-term births, mean birth weight, or the proportion of small-for-gestational-age infants among the treatment groups, suggesting that amlodipine is as effective as other treatments . However, a case report highlighted a lack of efficacy in a pregnant woman with severe hypertension, indicating that higher doses or additional medications might be necessary in some cases .
Pharmacokinetics and Placental Transfer
Research on the pharmacokinetics of amlodipine during the peripartum period revealed that the drug does cross the placenta but is not detected in breast milk or infant plasma at 24-48 hours postpartum, suggesting it is likely safe for use during this period . Another study confirmed that amlodipine transfers into breast milk at levels similar to plasma, but the relative infant dose remains below 10%, indicating a low risk for breastfeeding infants .
Amlodipine and Pregnancy Outcomes
A study on the combination of amlodipine and magnesium sulfate for treating gestational hypertension found that this regimen significantly reduced blood pressure and improved pregnancy outcomes compared to magnesium sulfate alone. The combination therapy was associated with lower incidences of postpartum hemorrhage, premature labor, placental abruption, neonatal respiratory distress, and neonatal death .
Amlodipine and Fertility
Interestingly, amlodipine has also been studied for its potential benefits in women with polycystic ovarian syndrome (PCOS). The drug was found to improve pre-ovulatory follicular blood flow, enhance follicular maturation, and increase the chances of conception when used alongside clomiphene citrate 38.
Conclusion
Overall, current research suggests that amlodipine is a safe and effective option for managing hypertension during pregnancy. It does not significantly increase the risk of congenital malformations and is compatible with breastfeeding. Additionally, it may offer benefits in improving fertility outcomes in women with PCOS. However, further large-scale clinical trials are necessary to confirm these findings and optimize treatment protocols.
Sources and full results
Most relevant research papers on this topic